Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14861660 | 0.98 | HIF1A (0.39) | HIF1ATSHRFAAHDPP7TRPV1 | |
| SCHEMBL14860861 | 0.98 | HIF1A (0.39) | HIF1ATSHRFAAHDPP7TRPV1 | |
| SCHEMBL6999656 | 0.96 | TSHR (0.39) | HIF1ATSHRFAAHDPP7TRPV1 | |
| Methylamine SCHEMBL27970224 | 0.94 | TSHR (0.38) | HIF1ATSHRFAAHDPP7TRPV1 | |
| SCHEMBL19043150 | 0.93 | TSHR (0.41) | HIF1ATSHRFAAHTRPV1 | |
| SCHEMBL14861453 | 0.93 | HIF1A (0.46) | HIF1ATSHRDPP7ABCB1 | |
| Methylamine SCHEMBL27970223 | 0.89 | HIF1A (0.42) | HIF1ATSHRFAAHDPP7TRPV1 | |
| SCHEMBL14765059 | 0.85 | DPP7 (0.35) | HIF1ADPP7 | |
| SCHEMBL16760833 | 0.83 | DPP7 (0.38) | HIF1ADPP7ABCB1 | |
| SCHEMBL16760832 | 0.83 | DPP7 (0.38) | HIF1ADPP7ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302710-A1 | SKIN CARE COMPOSITIONS CONTAINING A RETINOID WITH REDUCED MALODOR | THE PROCTER & GAMBLE COMPANY | 2025-10-02 | — | — | US | claimed |
| EP-4255375-B1 | HAIR CARE COMPOSITION COMPRISING MALODOR REDUCTION MATERIALS | PROCTER & GAMBLE (US) | 2025-08-13 | — | — | EP | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| US-12209232-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-28 | — | — | US | claimed |
| US-20230340375-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2023-10-26 | — | — | US | claimed |
| EP-4255375-A1 | HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| US-11732222-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2023-08-22 | — | — | US | claimed |
| CN-116568263-A | Hair care composition comprising malodor reduction materials | 宝洁公司 | 2023-08-08 | — | — | CN | claimed |
| WO-2022120109-A1 | HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-09 | — | — | WO | claimed |
| CN-113412327-A | Consumer product compositions with perfume encapsulates | 宝洁公司 | 2021-09-17 | — | — | CN | claimed |
| US-20200283705-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | THE PROCTER & GAMBLE COMPANY | 2020-09-10 | — | — | US | claimed |
| US-20140087988-A1 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2014-03-27 | — | — | US | claimed |
| EP-2709584-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. Mane Fils (FR) | 2014-03-26 | — | — | EP | claimed |
| WO-2012156649-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2012-11-22 | — | — | WO | claimed |
| US-20250302710-A1 | SKIN CARE COMPOSITIONS CONTAINING A RETINOID WITH REDUCED MALODOR | THE PROCTER & GAMBLE COMPANY | 2025-10-02 | — | — | US | disclosed |
| EP-4255375-B1 | HAIR CARE COMPOSITION COMPRISING MALODOR REDUCTION MATERIALS | PROCTER & GAMBLE (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | disclosed |
| WO-2012156649-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2012-11-22 | — | — | WO | disclosed |
| WO-2012156649-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2012-11-22 | — | — | WO | disclosed |
| WO-2012156649-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2012-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302710-A1 | SKIN CARE COMPOSITIONS CONTAINING A RETINOID WITH REDUCED MALODOR | RBP4, RARA, RBP1 | HIF1A 1933/4885TSHR 2099/4885FAAH 2912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.